Last reviewed · How we verify
NCT05392231: PS-GDM-2022
Assessment of Fetal Pancreatic Size and Maternal Serum Biomarkers in GDM
trial in Gestational Diabetes in 109 participants. Completed in 10 May 2022.
30 April 2022
Quick facts
| Lead sponsor | Haseki Training and Research Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 109 |
| Start date | 10 February 2022 |
| Primary completion | 30 April 2022 |
| Estimated completion | 10 May 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Conditions studied
- Gestational Diabetes — all drugs for Gestational Diabetes →
Sponsor
Haseki Training and Research Hospital
Who can join
Adults 18 to 42, female only, with Gestational Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators aimed to determine the predictive values of fetal pancreas size and maternal serum biomarkers glycated albumin (GA) and insulin-regulated aminopeptidase (IRAP) for gestational diabetes mellitus (GDM).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Fetal pancreas size and maternal serum biomarkers glycated albumin and insulin-regulated aminopeptidase provide no potential for early prediction of gestational diabetes mellitus.
Guleroglu FY, Ozmen AB, Bakirci IT, Dogu SY, et al · · 2023 · cited 7× · PMID 36436013 · DOI 10.1007/s00404-022-06860-2
Verify or expand the search:
- PubMed search for NCT05392231
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gestational Diabetes
Currently open trials in the same condition.
- NCT07171684 — Single vs Multi-Dose Insulin for Glycemic Control (SUGAR) · NA · recruiting
- NCT07314944 — Maternal Sleep and Lifestyle, Metabolic Health, and Perinatal Outcomes in Gestational Diabetes · recruiting
- NCT06571487 — Growth Hormone Resistance of Beta-cells · recruiting
- NCT07336914 — Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes · NA · recruiting
- NCT07174245 — Pregnancy and Postpartum CGM in GDM · recruiting
Other Haseki Training and Research Hospital trials
Trials by the same sponsor.
- NCT07502482 — The Effect of Magnesium on Post-spinal Headaches · not yet recruiting
- NCT07201181 — Maternal Smoking Exposure and Newborn Outcomes: Study Using Urinary Cotinine · not yet recruiting
- NCT07203716 — Preparing Kids for MRI Using VR · NA · not yet recruiting
- NCT07165743 — Evaluation of Fetal Bladder Emptying During the 11-14 Weeks' Ultrasound Examination as a Negative Predictive Marker for · active not recruiting
- NCT07179861 — Comparing Artificial Intelligence and Physicians: A Vignette-Based Study in Pediatric Clinical Decision-Making · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05392231 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Haseki Training and Research Hospital
- Last refreshed: 1 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05392231.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing